Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeystone Positive Change Investment Trust Regulatory News (KPC)

  • This share is currently suspended. It was suspended at a price of 223.00
  • There is currently no data for KPC

Doc Re: Glass Lewis Voting Recommendation

21 Jan 2025 07:00

RNS Number : 0157U
Keystone Positive Change I.T. PLC
21 January 2025
 

Keystone Positive Change Investment Trust plc (KPC)

 

Glass Lewis recommends shareholders vote "AGAINST" the Saba Resolutions

 

Keystone Positive Change Investment Trust plc ("KPC" or "the Company") notes the publication of the voting recommendation from Glass Lewis, the independent proxy advisor, in relation to the Company's general meeting to be held on 3 February 2025 at 12 noon (the "General Meeting").

 

Glass Lewis recommends that KPC shareholders vote "AGAINST" all the proposed Requisitioned Resolutions at the General Meeting on 3 February 2025.

 

In its report, Glass Lewis refers to a "lack of detail" in Saba's proposals and said its campaign is "more about obtaining influence than it is about offering shareholders a timely and certain exit." It also said Saba's intentions for the Board were not consistent with "the highest standards of governance".

 

The recommendation is consistent with the unanimous recommendation of the KPC independent board of directors.

 

Karen Brade, Chair of Keystone Positive Change plc, said:

 

"Shareholders should not be swayed by Saba's vague and theatrical promises - this is no knight in shining armour. Along with Glass Lewis, I have not encountered a single shareholder, analyst, or fund manager who believes Saba's proposals offer any benefit to anyone other than themselves.

 

"Saba is banking on shareholders not showing up to vote. I urge shareholders to prove Saba wrong. Vote against its self-serving campaign and let your independent board get on with implementing the plans that shareholders overwhelmingly said they wanted: the choice of an uncapped cash exit or the opportunity to roll into a more liquid fund with a similar strategy."

 

 

YOUR VOTE IS VERY IMPORTANT. The Requisitioned Resolutions are each being proposed as ordinary resolutions. This means that they only require more than 50 per cent of the votes cast to be voted in favour in order to pass. Saba has declared interests in approximately 28 per cent. of the Company's issued Ordinary Share capital. Therefore, the Board believes that other shareholders representing at least 30 per cent. of the Company's issued Ordinary Share capital are required to VOTE AGAINST the Requisitioned Resolutions in order to ensure they are blocked. FAILURE TO TAKE ACTION MAY LEAD TO SABA TAKING CONTROL OF YOUR COMPANY.

 

How to vote

 

The General Meeting to vote on the Requisitioned Resolutions will be held at the offices of Deutsche Numis, 45 Gresham Street, London EC2V 7BF on 3 February 2025 at 12 noon.

 

Investors who hold their Ordinary Shares through an investment platform provider or nominee are encouraged to contact their investment platform provider or nominee as soon as possible to arrange for VOTES AGAINST each of the Requisitioned Resolutions to be lodged on their behalf. Further information on how to vote through platforms can be found at the following link: https://www.theaic.co.uk/how-to-vote-your-shares

 

If shareholders have any questions as to how they can arrange for their investment platform provider or nominee to VOTE AGAINST each of the Requisitioned Resolutions or would like guidance on this process, they should email the Company's proxy solicitation agent at keystone@georgeson.com.

 

For further information please contact:

 

Deutsche Numis (Financial Adviser and Corporate Broker)

Nathan Brown

Tel: 020 7260 1426

Matt Goss

Tel: 020 7260 1642

 

Baillie Gifford & Co (Investment Manager)

Naomi Cherry

Tel 0131 275 2000

 

Greenbrook Advisory (PR Advisor)

Rob White, Peter Hewer and Ksenia Galouchko

Tel: 020 7952 2000

Email: KeystonePositiveChange@greenbrookadvisory.com

 

 

Important information

 

Capitalised terms used throughout this announcement shall have the meanings ascribed to them in the circular published by the Company on 6 January 2025, unless the context otherwise requires.

 

Neither the content of the websites referred to in this announcement, nor the content of any other website accessible from hyperlinks on such websites, is incorporated into, or forms part of, this announcement.

 

Legal Entity Identifier: 5493002H3JXLXLIGC563

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws

 

 

Baillie Gifford & Co Limited

Company Secretaries

21 January 2025

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCURRBRVRUAUAR
Date   Source Headline
19th Mar 20258:44 amRNSResults of Elections
18th Mar 202512:22 pmRNSNet Asset Value(s)
18th Mar 20257:30 amRNSSuspension - Keystone Positive Change I.T. PLC
17th Mar 20251:46 pmRNSResults of Meetings Adjourned from 27 January 2025
17th Mar 202512:00 pmRNSNet Asset Value(s)
14th Mar 202512:20 pmRNSNet Asset Value(s)
13th Mar 202511:20 amRNSNet Asset Value(s)
12th Mar 202511:15 amRNSNet Asset Value(s)
11th Mar 20256:00 pmRNSKeystone Positive Change Investment Trust
11th Mar 202512:33 pmRNSNet Asset Value(s)
10th Mar 202512:07 pmRNSNet Asset Value(s)
7th Mar 202512:30 pmRNSNet Asset Value(s)
6th Mar 202511:27 amRNSNet Asset Value(s)
5th Mar 202511:28 amRNSNet Asset Value(s)
4th Mar 202511:50 amRNSNet Asset Value(s)
3rd Mar 20251:34 pmRNSNet Asset Value(s)
28th Feb 202512:56 pmRNSNet Asset Value(s)
27th Feb 202512:08 pmRNSNet Asset Value(s)
26th Feb 202511:48 amRNSNet Asset Value(s)
25th Feb 202511:23 amRNSNet Asset Value(s)
24th Feb 202512:28 pmRNSNet Asset Value(s)
21st Feb 202512:08 pmRNSNet Asset Value(s)
20th Feb 20251:12 pmRNSNet Asset Value(s)
19th Feb 20252:42 pmRNSReconvening the Scheme Meetings and convening AGM
19th Feb 202512:00 pmRNSNet Asset Value(s)
18th Feb 202512:06 pmRNSNet Asset Value(s)
17th Feb 20252:56 pmRNSNet Asset Value(s)
14th Feb 202512:33 pmRNSNet Asset Value(s)
13th Feb 202511:23 amRNSNet Asset Value(s)
12th Feb 202511:17 amRNSNet Asset Value(s)
11th Feb 202511:42 amRNSNet Asset Value(s)
10th Feb 20251:15 pmRNSRelaunch of the Scheme
10th Feb 202511:38 amRNSNet Asset Value(s)
7th Feb 20254:49 pmRNSAdjournment of Scheme Meeting
7th Feb 202512:15 pmRNSNet Asset Value(s)
6th Feb 202511:02 amRNSNet Asset Value(s)
5th Feb 202510:59 amRNSNet Asset Value(s)
4th Feb 202511:55 amRNSNet Asset Value(s)
3rd Feb 20253:24 pmRNSResult of Requisitioned General Meeting
3rd Feb 20252:02 pmRNSNet Asset Value(s)
3rd Feb 202512:08 pmRNSTotal Voting Rights
31st Jan 202512:04 pmRNSNet Asset Value(s)
30th Jan 202512:18 pmRNSNet Asset Value(s)
29th Jan 202511:42 amRNSNet Asset Value(s)
28th Jan 20254:55 pmRNSTransaction in Own Shares
28th Jan 202512:28 pmRNSNet Asset Value(s)
27th Jan 20255:32 pmRNSTransaction in Own Shares
27th Jan 20254:11 pmRNSAnnouncement of Adjourned Meetings
27th Jan 202512:13 pmRNSNet Asset Value(s)
24th Jan 202511:58 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.